BR112016013623A2 - - Google Patents
Info
- Publication number
- BR112016013623A2 BR112016013623A2 BR112016013623A BR112016013623A BR112016013623A2 BR 112016013623 A2 BR112016013623 A2 BR 112016013623A2 BR 112016013623 A BR112016013623 A BR 112016013623A BR 112016013623 A BR112016013623 A BR 112016013623A BR 112016013623 A2 BR112016013623 A2 BR 112016013623A2
- Authority
- BR
- Brazil
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/507—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/14—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13197368 | 2013-12-16 | ||
| EP13197368.7 | 2013-12-16 | ||
| PCT/EP2014/077976 WO2015091493A1 (en) | 2013-12-16 | 2014-12-16 | Pancreatic islet-like cell structures and a method of preparing thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112016013623A2 true BR112016013623A2 (pt) | 2017-08-08 |
| BR112016013623B1 BR112016013623B1 (pt) | 2023-03-21 |
Family
ID=49765387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016013623-3A BR112016013623B1 (pt) | 2013-12-16 | 2014-12-16 | Método de preparação de uma estrutura de célula esferoide semelhante à ilhota pancreática cultivada artificialmente, e uso de uma estrutura de célula esferoide |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10174286B2 (pt) |
| EP (1) | EP3083941B1 (pt) |
| JP (2) | JP6643993B2 (pt) |
| KR (1) | KR102338815B1 (pt) |
| CN (2) | CN111635883A (pt) |
| AU (1) | AU2014364632B2 (pt) |
| BR (1) | BR112016013623B1 (pt) |
| CA (1) | CA2933135C (pt) |
| DK (1) | DK3083941T3 (pt) |
| ES (1) | ES2941686T3 (pt) |
| WO (1) | WO2015091493A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ603482A (en) | 2010-05-12 | 2014-11-28 | Tengion Inc | Bioactive renal cells |
| WO2020035480A1 (en) | 2018-08-16 | 2020-02-20 | Unicyte Islet Ag | Viable pancreatic islet-like cell structures and a method of preparing thereof |
| EP3816276A1 (en) | 2019-10-31 | 2021-05-05 | Unicyte Islet AG | Viable pancreatic islet-like cell structures and a method of preparing thereof |
| CN113637630B (zh) * | 2020-05-11 | 2024-03-29 | 中国科学院分子细胞科学卓越创新中心 | 一种胰岛样细胞团及其制法和应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0348490B1 (en) * | 1988-01-11 | 1995-09-27 | Amylin Pharmaceuticals, Inc. | Treatment of type 2 diabetes mellitus |
| AU4330597A (en) * | 1996-08-30 | 1998-03-19 | Life Technologies, Inc. | Serum-free mammalian cell culture medium, and uses thereof |
| US6129911A (en) | 1998-07-10 | 2000-10-10 | Rhode Island Hospital, A Lifespan Partner | Liver stem cell |
| DK1147179T3 (da) | 1999-01-19 | 2009-03-09 | Univ North Carolina | Humane lever-progenitorer |
| US7456017B2 (en) | 1999-10-01 | 2008-11-25 | University Of North Carolina At Chapel Hill | Processes for clonal growth of hepatic progenitor cells |
| US20010046489A1 (en) * | 1999-12-06 | 2001-11-29 | Habener Joel E. | Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| JP4344231B2 (ja) | 2001-05-16 | 2009-10-14 | 財団法人神奈川科学技術アカデミー | ｄｌｋを用いた未分化肝細胞の検出及び分離方法 |
| EP1264879A1 (en) * | 2001-06-08 | 2002-12-11 | Leadd B.V. | Isolation of a cluster of cells from an isolated organ using magnetic particle |
| US20050053588A1 (en) | 2001-10-18 | 2005-03-10 | Li Yin | Conversion of liver stem and progenitor cells to pancreatic functional cells |
| CA2692325C (en) * | 2001-12-07 | 2015-10-20 | Geron Corporation | Islet cells from human embryonic stem cells |
| US20030162290A1 (en) * | 2002-01-25 | 2003-08-28 | Kazutomo Inoue | Method for inducing differentiation of embryonic stem cells into functioning cells |
| HUE032238T2 (en) | 2002-03-15 | 2017-09-28 | Univ North Carolina Chapel Hill | Primitive and proximal liver stem cells |
| CN1536075A (zh) * | 2003-04-09 | 2004-10-13 | 中国人民解放军军事医学科学院野战输 | 一种诱导骨髓间充质干细胞向胰岛样细胞分化的方法 |
| CA2531312A1 (en) * | 2003-07-29 | 2005-02-17 | Unilever Plc | Food product comprising phytosterols |
| US20050074876A1 (en) | 2003-10-03 | 2005-04-07 | Inserm | Bipotential liver cell lines from wild-type mammalian liver tissue |
| US7485434B2 (en) * | 2005-04-04 | 2009-02-03 | The Salk Institute For Biological Studies | Method for screening compounds for those that modulate transducers of regulated CREB activity |
| US7507581B2 (en) * | 2005-04-05 | 2009-03-24 | Synthecon, Inc. | Inhibition of pancreatic islet aggregation |
| WO2006126219A1 (en) * | 2005-05-26 | 2006-11-30 | Fresenius Medical Care Deutschland G.M.B.H. | Liver progenitor cells |
| JP5131833B2 (ja) * | 2005-10-05 | 2013-01-30 | 晃文 松山 | 脂肪組織由来細胞から膵内分泌細胞を得る方法 |
| CN101356264B (zh) * | 2005-12-21 | 2014-05-14 | 鲁汶大学 | 分离的肝脏干细胞 |
| US7716503B2 (en) | 2006-12-14 | 2010-05-11 | Inventec Corporation | Extension card incorporating power management device |
| JP5196522B2 (ja) * | 2007-06-27 | 2013-05-15 | 国立大学法人東北大学 | 移植用膵島の評価方法 |
| CN101896188B (zh) * | 2007-10-15 | 2013-01-02 | 弗雷森纽斯医疗护理德国有限责任公司 | 微泡(mv)用于制备对内皮细胞移植具有佐剂活性、特别是对通过胰岛移植进行的糖尿病治疗具有佐剂活性的药物的用途，和相关方法 |
| GB0800524D0 (en) * | 2008-01-14 | 2008-02-20 | Univ Brighton | Cell culture system |
| US20110008301A1 (en) * | 2008-03-15 | 2011-01-13 | Trivedi H L | Human adipose derived insulin making mesenchymal stem cells for treating diabetes mellitus |
| CN101550406B (zh) | 2008-04-03 | 2016-02-10 | 北京大学 | 制备多潜能干细胞的方法,试剂盒及用途 |
| CN101603027A (zh) * | 2008-06-12 | 2009-12-16 | 西北农林科技大学 | 体外诱导人骨髓间充质干细胞分化为胰岛样细胞的方法 |
| EP2393917B1 (en) * | 2009-02-03 | 2016-04-06 | Koninklijke Nederlandse Akademie van Wetenschappen | Culture medium for epithelial stem cells and organoids comprising said stem cells. |
| CN102433300A (zh) * | 2011-11-25 | 2012-05-02 | 厚朴生物科技（苏州）有限公司 | 一种人胰岛来源的胰腺干细胞系的构建及向胰岛素分泌细胞分化的方法 |
| CN102517248A (zh) * | 2011-12-30 | 2012-06-27 | 中日友好医院 | 一种体外诱导胰岛样结构形成的方法 |
-
2014
- 2014-12-16 EP EP14812530.5A patent/EP3083941B1/en active Active
- 2014-12-16 JP JP2016539196A patent/JP6643993B2/ja active Active
- 2014-12-16 AU AU2014364632A patent/AU2014364632B2/en active Active
- 2014-12-16 DK DK14812530.5T patent/DK3083941T3/da active
- 2014-12-16 BR BR112016013623-3A patent/BR112016013623B1/pt active IP Right Grant
- 2014-12-16 WO PCT/EP2014/077976 patent/WO2015091493A1/en active Application Filing
- 2014-12-16 CN CN202010376029.5A patent/CN111635883A/zh active Pending
- 2014-12-16 ES ES14812530T patent/ES2941686T3/es active Active
- 2014-12-16 US US15/103,317 patent/US10174286B2/en active Active
- 2014-12-16 KR KR1020167019032A patent/KR102338815B1/ko active IP Right Grant
- 2014-12-16 CN CN201480067754.7A patent/CN105814193B/zh active Active
- 2014-12-16 CA CA2933135A patent/CA2933135C/en active Active
-
2018
- 2018-11-29 US US16/203,869 patent/US11453863B2/en active Active
-
2019
- 2019-10-03 JP JP2019182785A patent/JP2020014477A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US11453863B2 (en) | 2022-09-27 |
| KR20160098439A (ko) | 2016-08-18 |
| US10174286B2 (en) | 2019-01-08 |
| AU2014364632B2 (en) | 2021-04-01 |
| ES2941686T3 (es) | 2023-05-24 |
| JP2017500859A (ja) | 2017-01-12 |
| CA2933135C (en) | 2023-08-01 |
| DK3083941T3 (da) | 2023-03-13 |
| EP3083941B1 (en) | 2023-02-22 |
| WO2015091493A1 (en) | 2015-06-25 |
| CA2933135A1 (en) | 2015-06-25 |
| KR102338815B1 (ko) | 2021-12-13 |
| AU2014364632A1 (en) | 2016-06-16 |
| BR112016013623B1 (pt) | 2023-03-21 |
| CN111635883A (zh) | 2020-09-08 |
| CN105814193A (zh) | 2016-07-27 |
| CN105814193B (zh) | 2020-05-08 |
| EP3083941A1 (en) | 2016-10-26 |
| US20190119648A1 (en) | 2019-04-25 |
| JP6643993B2 (ja) | 2020-02-12 |
| JP2020014477A (ja) | 2020-01-30 |
| US20160312189A1 (en) | 2016-10-27 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/12/2014, OBSERVADAS AS CONDICOES LEGAIS |